Bi XC, Pu XY, Liu JM and Huang S 2017 Effect of transcription factor E2F1 expression on the invasion of prostate cancer. Zhonghua Yi Xue Za Zhi 97 2856–2859

CAS  Google Scholar 

Burden DA, Kingma PS, Froelich-Ammon SJ, et al. 1996 Topoisomerase II.etoposide interactions direct the formation of drug-induced enzyme-DNA cleavage complexes. J. Biol. Chem. 271 29238–29244

Article  CAS  Google Scholar 

Chun JN, Cho M, Park S, So I and Jeon JH 2020 The conflicting role of E2F1 in prostate cancer: A matter of cell context or interpretational flexibility? Biochim. Biophys. Acta Rev. Cancer 1873 188336

Article  CAS  Google Scholar 

Cui Y, Pu R, Ye J, et al. 2020 LncRNA FAM230B promotes gastric cancer growth and metastasis by regulating the miR-27a-5p/TOP2A axis. Dig. Dis. Sci. 66 2637–2650

Article  Google Scholar 

Denechaud PD, Fajas L and Giralt A 2017 E2F1, a novel regulator of metabolism. Front. Endocrinol. 8 311

Article  Google Scholar 

Deng J, Zhang J, Ye Y, et al. 2021 N(6)-methyladenosine-mediated upregulation of WTAPP1 promotes WTAP translation and Wnt signaling to facilitate pancreatic cancer progression. Cancer Res. 81 5268–5283

Article  CAS  Google Scholar 

Ertosun MG, Hapil FZ and Osman NO 2016 E2F1 transcription factor and its impact on growth factor and cytokine signaling. Cytokine Growth Factor Rev. 31 17–25

Article  Google Scholar 

Fang Z, Lin M, Li C, Liu H and Gong C 2020a A comprehensive review of the roles of E2F1 in colon cancer. Am. J. Cancer Res. 10 757–768

CAS  Google Scholar 

Fang Z, Wang Y, Wang Z, et al. 2020 ERINA is an estrogen-responsive LncRNA that drives breast cancer through the E2F1/RB1 pathway. Cancer Res. 80 4399–4413

Article  CAS  Google Scholar 

Ghafouri-Fard S and Taheri M 2020 Long non-coding RNA signature in gastric cancer. Exp. Mol. Pathol. 113 104365

Article  CAS  Google Scholar 

Giannone G, Milani A, Ghisoni E, et al. 2018 Oral etoposide in heavily pre-treated metastatic breast cancer: A retrospective series. Breast 38 160–164

Article  CAS  Google Scholar 

Guo W, Sun S, Guo L, et al. 2020 Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics. J. Cancer Res. Clin. Oncol. 146 821–841

Article  CAS  Google Scholar 

Han R, Zhao J and Lu L 2020 MicroRNA34a expression affects breast cancer invasion in vitro and patient survival via downregulation of E2F1 and E2F3 expression. Oncol. Rep. 43 2062–2072

CAS  Google Scholar 

He X and Shu Y 2020 miR-452 promotes the development of gastric cancer via targeting EPB41L3. Pathol. Res. Pract. 216 152725

Article  CAS  Google Scholar 

Lee JH and Berger JM 2019 Cell cycle-dependent control and roles of DNA topoisomerase II. Genes 10 859

Article  CAS  Google Scholar 

Liu T, Zhang H, Yi S, Gu L and Zhou M 2019 Mutual regulation of MDM4 and TOP2A in cancer cell proliferation. Mol. Oncol. 13 1047–1058

Article  CAS  Google Scholar 

Luo Z, Rong Z, Zhang J, et al. 2020 Circular RNA circCCDC9 acts as a miR-6792–3p sponge to suppress the progression of gastric cancer through regulating CAV1 expression. Mol. Cancer 2020 86

Article  Google Scholar 

Manicum T, Ni F, Ye Y, Fan X and Chen BC 2018 Prognostic values of E2F mRNA expression in human gastric cancer. Biosci. Rep. 38 BSR20181264

Article  Google Scholar 

Marsh AM and Buicko JL 2021 Gastric resection; in StatPearls (Treasure Island, FL)

Matsuzaki J, Tsugawa H and Suzuki H 2021 Precision medicine approaches to prevent gastric cancer. Gut Liver 15 3–12

Article  CAS  Google Scholar 

Mukkamalla SKR, Recio-Boiles A and Babiker HM 2021 Gastric cancer; in StatPearls (Treasure Island, FL)

Niu W, Guo LY, Zhang JY, et al. 2020 E2F1-induced upregulation of lncRNA HCG18 stimulates proliferation and migration in gastric cancer by binding to miR-197-3p. Eur. Rev. Med. Pharmacol. Sci. 24 9949–9956

CAS  Google Scholar 

Odero-Marah V, Hawsawi O, Henderson V and Sweeney J 2018 Epithelial-mesenchymal transition (EMT) and prostate cancer. Adv. Exp. Med. Biol. 1095 101–110

Article  CAS  Google Scholar 

Paroha S, Verma J, Dubey RD, et al. 2021 Recent advances and prospects in gemcitabine drug delivery systems. Int. J. Pharmaceut. 592 120043

Article  CAS  Google Scholar 

Sapetto-Rebow B, McLoughlin SC, O’Shea LC, et al. 2011 Maternal topoisomerase II alpha, not topoisomerase II beta, enables embryonic development of zebrafish top2a-/- mutants. BMC Dev. Biol. 11 71

Article  CAS  Google Scholar 

Seidlitz T, Koo BK and Stange DE 2021 Gastric organoids-an in vitro model system for the study of gastric development and road to personalized medicine. Cell Death Differ. 28 68–83

Article  Google Scholar 

Song L, Robson T, Doig T, Brenn T, et al. 2013 DNA repair and replication proteins as prognostic markers in melanoma. Histopathology 62 343–350

Article  Google Scholar 

Sun CC, Zhou Q, Hu W, et al. 2018 Transcriptional E2F1/2/5/8 as potential targets and transcriptional E2F3/6/7 as new biomarkers for the prognosis of human lung carcinoma. Aging 10 973–987

Article  CAS  Google Scholar 

Sun KK and Wu YY 2021 Current status of laparoscopic proximal gastrectomy in proximal gastric cancer: Technical details and oncologic outcomes. Asian J. Surg. 44 54–58

Article  Google Scholar 

Tan Z 2019 Recent advances in the surgical treatment of advanced gastric cancer: A review. Med. Sci. Monit. 25 3537–3541

Article  Google Scholar 

Telford WG 2018 Multiparametric analysis of apoptosis by flow cytometry. Methods Mol. Biol. 1678 167–202

Article  CAS  Google Scholar 

Tian S, Zhang L, Li Y, et al. 2020 Human Papillomavirus E7 oncoprotein promotes proliferation and migration through the transcription factor E2F1 in cervical cancer cells. Anticancer Agents Med. Chem. 21 1689–1696

Article  Google Scholar 

Wang B, Guan G and Zhao D 2020 Silence of FAM83H-AS1 promotes chemosensitivity of gastric cancer through Wnt/beta-catenin signaling pathway. Biomed. Pharmacother. 125 109961

Article  CAS  Google Scholar 

Xu TP, Wang YF, Xiong WL, et al. 2017 E2F1 induces TINCR transcriptional activity and accelerates gastric cancer progression via activation of TINCR/STAU1/CDKN2B signaling axis. Cell Death Dis. 8 e2837

Article  CAS  Google Scholar 

Yang Z, Liu Y, Shi C, et al. 2017 Suppression of PTEN/AKT signaling decreases the expression of TUBB3 and TOP2A with subsequent inhibition of cell growth and induction of apoptosis in human breast cancer MCF-7 cells via ATP and caspase-3 signaling pathways. Oncol. Rep. 37 1011–1019

Article  CAS  Google Scholar 

Yu X, Davenport JW, Urtishak KA, et al. 2017 Genome-wide TOP2A DNA cleavage is biased toward translocated and highly transcribed loci. Genome Res. 27 1238–1249

Article  CAS  Google Scholar 

Yu Y, Zhao D, Li K, et al. 2020 E2F1 mediated DDX11 transcriptional activation promotes hepatocellular carcinoma progression through PI3K/AKT/mTOR pathway. Cell Death Dis. 11 273

Article  CAS  Google Scholar 

Yuan L, Xu ZY, Ruan SM, et al. 2020 Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance. Mol. Cancer 19 96

Article  CAS  Google Scholar 

Zhang R, Xu J, Zhao J and Bai JH 2018 Proliferation and invasion of colon cancer cells are suppressed by knockdown of TOP2A. J. Cell Biochem. 119 7256–7263

Article  CAS  Google Scholar 

Zhang Y and Weinberg RA 2018 Epithelial-to-mesenchymal transition in cancer: complexity and opportunities. Front. Med. 12 361–373

Article  Google Scholar 

Zheng C, Ren Z, Wang H, et al. 2009 E2F1 Induces tumor cell survival via nuclear factor-kappaB-dependent induction of EGR1 transcription in prostate cancer cells. Cancer Res. 69 2324–2331

Article  CAS  Google Scholar 

Zhu G, Shen Q, Jiang H, et al. 2020a Curcumin inhibited the growth and invasion of human monocytic leukaemia SHI-1 cells in vivo by altering MAPK and MMP signalling. Pharm. Biol. 58 25–34

Article  CAS  Google Scholar 

Zhu J, Wang SM, Chen R, Li XQ and Wei WW 2020b Progress on screening for gastric cancer. Zhonghua Zhong Liu Za Zhi 42 603–608

CAS  Google Scholar